The search for the target antigens of multiple sclerosis, part 2: CD8+ T cells, B cells, and antibodies in the focus of reverse-translational research-Reference-Cited by-同舟云学术

The search for the target antigens of multiple sclerosis, part 2: CD8+ T cells, B cells, and antibodies in the focus of reverse-translational research

Published:2016-03 Issue:3 Volume:15 Page:317-331
ISSN:1474-4422
Container-title:The Lancet Neurology
language:en
Short-container-title:The Lancet Neurology

Author:

Hohlfeld Reinhard,Dornmair Klaus,Meinl Edgar,Wekerle Hartmut

Publisher

Elsevier BV

Subject

Clinical Neurology

Reference178 articles.

1. The search for the target antigens of multiple sclerosis, part 1: autoreactive CD4+ T lymphocytes as pathogenic effectors and therapeutic targets;Hohlfeld;Lancet Neurol,2015

2. The role of CD8(+) T cells in multiple sclerosis and its animal models;Goverman;Curr Drug Targets Inflamm Allergy,2005

3. Pathogenic CD8(+) T cells in multiple sclerosis;Friese;Ann Neurol,2009

4. Role of CD8 T cell subsets in the pathogenesis of multiple sclerosis;Saxena;FEBS Lett,2011

5. Selection of self-reactive T cells in the thymus;Stritesky;Annu Rev Immunol,2012

Cited by 158 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. New views on the complex interplay between degeneration and autoimmunity in multiple sclerosis;Frontiers in Cellular Neuroscience;2024-08-05

2. Novel and Emerging Treatments to Target Pathophysiological Mechanisms in Various Phenotypes of Multiple Sclerosis;Pharmacological Reviews;2024-05-06

3. The distinction of area postrema syndrome between MOGAD and NMOSD;Heliyon;2024-05

4. Prospective study validating a multidimensional treatment decision score predicting the 24-month outcome in untreated patients with clinically isolated syndrome and early relapsing–remitting multiple sclerosis, the ProVal-MS study;Neurological Research and Practice;2024-03-07

5. T cells in multiple sclerosis;Mechanisms of Disease Pathogenesis in Multiple Sclerosis;2024